meglumine has been researched along with Infarction, Middle Cerebral Artery in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, L; Cao, ZY; Ke, ZP; Li, ZQ; Wang, ZZ; Xiao, W | 1 |
Du, GH; Li, L; Song, JK; Wang, ZZ; Xiao, W; Xiao, ZY; Yan, R; Zhang, W; Zhou, WX | 1 |
Al-Zghlou, M; Alonso, A; Böhme, J; Förster, A; Groden, C; Wenz, H | 1 |
Annan, M; Cazals, X; Cottier, JP; Debiais, S; Dejobert, M; Lauvin, MA | 1 |
4 other study(ies) available for meglumine and Infarction, Middle Cerebral Artery
Article | Year |
---|---|
[Cerebral vascular protective effect of ginkgo diterpene lactone meglumine injection].
Topics: Animals; Blood-Brain Barrier; Brain Edema; Brain Ischemia; Diterpenes; Ginkgo biloba; Infarction, Middle Cerebral Artery; Lactones; Matrix Metalloproteinase 9; Meglumine; Rats | 2017 |
Diterpene ginkgolides protect against cerebral ischemia/reperfusion damage in rats by activating Nrf2 and CREB through PI3K/Akt signaling.
Topics: Animals; Brain Edema; Cyclic AMP Response Element-Binding Protein; Ginkgo biloba; Ginkgolides; Heme Oxygenase (Decyclizing); Infarction, Middle Cerebral Artery; Male; Meglumine; Neuroprotective Agents; NF-E2-Related Factor 2; PC12 Cells; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction | 2018 |
Assessment of collateral blood flow in patients with distal branch occlusion of the middle cerebral artery.
Topics: Aged; Aged, 80 and over; Cerebral Angiography; Collateral Circulation; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Infarction, Middle Cerebral Artery; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Stroke | 2019 |
Susceptibility-Diffusion Mismatch in Hyperacute Stroke: Correlation with Perfusion-Diffusion Mismatch and Clinical Outcome.
Topics: Aged; Aged, 80 and over; Blood Flow Velocity; Cerebrovascular Circulation; Contrast Media; Diffusion Magnetic Resonance Imaging; Disability Evaluation; Female; Humans; Infarction, Middle Cerebral Artery; Injections, Intravenous; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Perfusion Imaging; Predictive Value of Tests; Prospective Studies; Reproducibility of Results; Thrombolytic Therapy; Time Factors; Treatment Outcome | 2016 |